Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5EOC

Crystal structure of Fab C2 in complex with a Cyclic variant of Hepatitis C Virus E2 epitope I

5EOC の概要
エントリーDOI10.2210/pdb5eoc/pdb
分子名称Fab fragment (Heavy chain), Fab fragment (Light chain), ALA-CYS-GLN-LEU-ILE-ASN-THR-ASN-GLY-SER-TRP-HIS-ILE-CYS, ... (5 entities in total)
機能のキーワードcomplex, monoclonal antibodies, hcv, immune system
由来する生物種Mus musculus
詳細
タンパク質・核酸の鎖数6
化学式量合計97541.86
構造登録者
Berisio, R.,Ruggiero, A.,Sandomenico, A.,Patel, A.H.,Ruvo, M.,Vitagliano, L. (登録日: 2015-11-10, 公開日: 2016-02-10, 最終更新日: 2024-11-20)
主引用文献Sandomenico, A.,Leonardi, A.,Berisio, R.,Sanguigno, L.,Foca, G.,Foca, A.,Ruggiero, A.,Doti, N.,Muscariello, L.,Barone, D.,Farina, C.,Owsianka, A.,Vitagliano, L.,Patel, A.H.,Ruvo, M.
Generation and Characterization of Monoclonal Antibodies against a Cyclic Variant of Hepatitis C Virus E2 Epitope 412-422.
J.Virol., 90:3745-3759, 2016
Cited by
PubMed Abstract: The hepatitis C virus (HCV) E2 envelope glycoprotein is crucial for virus entry into hepatocytes. A conserved region of E2 encompassing amino acids 412 to 423 (epitope I) and containing Trp420, a residue critical for virus entry, is recognized by several broadly neutralizing antibodies. Peptides embodying this epitope I sequence adopt a β-hairpin conformation when bound to neutralizing monoclonal antibodies (MAbs) AP33 and HCV1. We therefore generated new mouse MAbs that were able to bind to a cyclic peptide containing E2 residues 412 to 422 (C-epitope I) but not to the linear counterpart. These MAbs bound to purified E2 with affinities of about 50 nM, but they were unable to neutralize virus infection. Structural analysis of the complex between C-epitope I and one of our MAbs (C2) showed that the Trp420 side chain is largely buried in the combining site and that the Asn417 side chain, which is glycosylated in E2 and solvent exposed in other complexes, is slightly buried upon C2 binding. Also, the orientation of the cyclic peptide in the antibody-combining site is rotated by 180° compared to the orientations of the other complexes. All these structural features, however, do not explain the lack of neutralization activity. This is instead ascribed to the high degree of selectivity of the new MAbs for the cyclic epitope and to their inability to interact with the epitope in more flexible and extended conformations, which recent data suggest play a role in the mechanisms of neutralization escape.
PubMed: 26819303
DOI: 10.1128/JVI.02397-15
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.98 Å)
構造検証レポート
Validation report summary of 5eoc
検証レポート(詳細版)ダウンロードをダウンロード

248335

件を2026-01-28に公開中

PDB statisticsPDBj update infoContact PDBjnumon